Oral contraceptive pill for heavy menstrual bleeding

Area of Science:

• Gynecology
• Pharmacology

Background:

• Menorrhagia, or heavy menstrual bleeding, is a common and debilitating condition.
• Current treatments include hormonal therapies, prostaglandin inhibitors, and antifibrinolytics.
• Combined oral contraceptive pills (OCP) are proposed to treat menorrhagia by regulating endometrial shedding and inhibiting ovulation.

Purpose of the Study:

• To evaluate the effectiveness of oral contraceptive pills (OCP) for treating heavy menstrual bleeding.
• Comparison of OCP against other medical therapies, placebo, or no treatment.

Main Methods:

• Systematic review of randomized controlled trials comparing OCP with other treatments for menorrhagia.
• Searches conducted across multiple databases including MEDLINE, EMBASE, and CENTRAL.
• Inclusion criteria: randomized trials in women of reproductive age with heavy menstrual bleeding and at least two months follow-up.

Main Results:

• Only one small trial involving 45 women met the inclusion criteria.
• No significant difference in menstrual blood loss was found between OCP, danazol, mefenamic acid, or naproxen groups.
• Data analysis focused on the first treatment period of the cross-over design trial.

Conclusions:

• A single small study found no significant difference in efficacy between OCP and other medical treatments for menorrhagia.
• The limited evidence from this one study is insufficient to determine the effectiveness of OCP for heavy menstrual bleeding.
• The review could not meet its objectives due to a lack of sufficient data.